Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Does anesthesia choice affect inflammation after kidney stone surgery?

NCT ID NCT07205224

Knowledge-focused Sponsor: Sevim Şenol Karataş Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 90 adults having kidney stone surgery to see if the type of anesthesia (spinal or general) changes inflammation levels after the procedure. Researchers used standard blood tests taken before and after surgery to measure inflammation. No extra blood draws or treatments were given beyond normal care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

90 people

The number who actually took part.

Started

Sep 2025

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients (≥18 years, ASA I-III) scheduled for percutaneous nephrolithotomy (PCNL) at a single tertiary care center. Eligible patients will be assigned to spinal or general anesthesia groups based on routine clinical decision-making. Routine perioperative laboratory values (NLR, RDW, LAR) will be collected preoperatively and postoperatively.

Ages

18 to 99 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Age ≥18 years ASA physical status I-III Scheduled for percutaneous nephrolithotomy (PCNL) Provided informed consent Exclusion Criteria: Active infection or sepsis Known malignancy Chronic inflammatory or autoimmune disease (e.g., rheumatoid arthritis, systemic lupus erythematosus) Current immunosuppressive therapy Pregnancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Nephrolithiasis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

nephrolithiasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Nephrolithiasis Postoperative inflammation

Contacts and locations

Locations

  • Elazığ Fethi Sekin City Hospital

    Elâzığ, Merkez, 23200, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.